Average Daily Range |
Avg Daily Range: |
$0.36 | 4.20%
|
Avg Daily Range (30 D): |
$0.10 | 4.55%
|
Avg Daily Range (90 D): |
$0.10 | 4.05%
|
Institutional Daily Volume |
Avg Daily Volume: |
.35M |
Avg Daily Volume (30 D): |
.29M |
Avg Daily Volume (90 D): |
.3M |
Trade Size |
Avg Trade Size (Sh.): |
96 |
Avg Trade Size (Sh.) (30 D): |
133 |
Avg Trade Size (Sh.) (90 D): |
126 |
Institutional Trades |
Total Inst.Trades: |
108 |
Avg Inst. Trade: |
$1.86M |
Avg Inst. Trade (30 D): |
$3.27M |
Avg Inst. Trade (90 D): |
$3.27M |
Avg Inst. Trade Volume: |
.14M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.67M |
Avg Closing Trade (30 D): |
$3.06M |
Avg Closing Trade (90 D): |
$3.06M |
Avg Closing Volume: |
213.96K |
|
|
|
|
News |
Mar 18, 2025 @ 8:48 PM
Notice to Long-Term Shareholders of Archer-Daniels...
Source: Grabar Law Office
|
Mar 13, 2025 @ 10:21 PM
Long-Term Shareholder Notice: Fluence Energy, Inc....
Source: Grabar Law Office
|
Mar 5, 2025 @ 6:00 PM
CAR T-cell Therapy Clinical Trial Pipeline Experie...
Source: Delveinsight
|
Feb 6, 2025 @ 6:51 PM
Investors in Kyverna Therapeutics, Inc. Should Con...
Source: The Gross Law Firm
|
Feb 3, 2025 @ 9:00 PM
KYTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-3.38
|
$-1.03
|
$-.88
|
Diluted EPS
|
$-3.38
|
$-1.03
|
$-.88
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -145.42M
|
$ -44.64M
|
$ -37.49M
|
Operating Income / Loss
|
$ -160.65M
|
$ -47.41M
|
$ -41.04M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -167.44M
|
$ -39.75M
|
$ -8.05M
|
PE Ratio
|
|
|
|
|